Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WASP family homolog 6, pseudogene (WASH6P) is officially classified as a pseudogene in humans, meaning it is a DNA sequence related to a functional gene that does not produce a functional protein[1][2]. While predicted functional annotations suggest possible roles in alpha- and gamma-tubulin binding, Arp2/3 complex-mediated actin nucleation, and endosomal trafficking, these are inferred based on homology and not experimentally confirmed in humans[1][3][4][7]. WASH6P is part of the WASH family, involved in actin dynamics, but unlike the functional paralog WASHC1, WASH6P has no established protein product or direct biological activity. It is not considered a true drug target, does not have disease associations, biomarkers, or known safety concerns due to its pseudogene status[1][2][6]. Alternative names include CXYorf1 and FAM39A, but WASH6P is the canonical abbreviation.
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WASP family homolog 6, pseudogene (WASH6P).